Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NSI-189 Phase 2 in MDD
NCT02695472Phase 2Unknown
- Sponsor
- Seneca Biopharma
- Start
- Mar 2016
- Primary completion
- Jun 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of amdiglurax in major depressive disorder (MDD), sponsored by Seneca Biopharma. Status: unknown.
02
Drugs
amdiglurax
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT02695472.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02695472.